Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Increasing Incidence of Nerve Injuries
    3. Market Restraints
      1. High Cost of Treatment and Procedures
      2. Limited Availability of Skilled Professionals
    4. Market Opportunity
      1. Growing Research in Neurology
    5. Market Trends
      1. Rising Adoption of Biomaterials and Nerve Grafts
      2. Growth in Stem Cell-Based Therapies
  5. MARKET SEGMENTATION
    1. By Product
      1. Neurostimulation
      2. Neuromodulation Devices
      3. Biomaterials
    2. By Indication
      1. Failed Back Surgery Syndrome
      2. Parkinson's Disease
      3. Urinary Incontinence
      4. Epilepsy
      5. Gastroparesis, Nerve Repair
      6. Grafting
    3. By Application
      1. Neurostimulation
      2. Neuromodulation Surgeries
      3. Neurorrhaphy
      4. Nerve Grafting
      5. Stem Cell Therapy
    4. By End User
      1. Hospitals and Clinics
      2. Ambulatory Surgical Centres
    5. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. Abbott
      2. AxoGen, Inc.
      3. Boston Scientific
      4. BioWave Corporation
      5. Baxter International, Inc.
      6. Cyberonics, Inc.
      7. Collagen Matrix, Inc.
      8. Checkpoint Surgical, Inc.
      9. Integra LifeSciences
      10. KeriMedical
      11. LivaNova PLC
      12. Medtronic Plc
      13. Nuvectra
      14. Nevro Corp
      15. NeuroPace, Inc.
      16. NeuroSigma
      17. OrthoMed, Inc.
      18. Polyganics
      19. Stryker
      20. Synovis Micro Companies Alliance, Inc.
      21. Soterix Medical, Inc.
      22. Synapse Biomedical, Inc.
  7. MARKET OPPORTUNITIES AND FUTURE TREND


Frequently Asked Questions

Q.1. What is the projected market value of the global Nerve Repair and Regenerationmarket?

The global market of nerve repair and regenerationis projected to reach USD33.4 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Nerve Repair and Regenerationmarket?

The global nerve repair and regenerationmarket has an estimated annual growth rate of 10.7%.

Q.3. What are the recent trends of Nerve Repair and Regenerationmarket?

Rising adoption of biomaterials and nerve graftsand growth in stem cell-based therapies are some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in Nerve Repair and Regeneration?

The major companies profiled in this report include Abbott, AxoGen, Inc., Boston Scientific, BioWave Corporation, Baxter International, Inc., Cyberonics, Inc., Collagen Matrix, Inc., Checkpoint Surgical, Inc., Integra LifeSciences, KeriMedical, LivaNova PLC, Medtronic Plc, Nuvectra, Nevro Corp, NeuroPace, Inc., NeuroSigma, OrthoMed, Inc., Polyganics, Stryker, Synovis Micro Companies Alliance, Inc., Soterix Medical, Inc., Synapse Biomedical, Inc., among others.   

Q.5. Which is the largest regional market in the Nerve Repair and Regeneration?

North America is the largest regional market for nerve repair and regeneration.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.